COVID-19 WebinarsGlobal Health

COVID-19: The Invisible Impact on Team Members

By May 19, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

This webinar was previously recorded on May 13th, 2020 and is now available on demand.
Join colleagues and thought leaders as we examine the emotional and logistical impact of COVID-19 on employees. Panelists will discuss job loss, mental wellbeing, employee’s top concerns and communication surrounding the global coronavirus pandemic.
Experts will discuss ways to offset anxiety and depression, steps to take care of your emotional well-being and logistical challenges such as homeschooling and balancing the ever-changing priorities during this crisis. There will also be discussion surrounding manager communication strategies, what works, what does not work and ways employers can calm employee’s fears during the pandemic.

Moderator

  • Brandon Thompson
    (Co-Founder, Careers in Aesthetics & Co-Founder & CEO, BNB Aesthetic Innovations)

Faculty

  • Richard G. Fried, MD, PhD
    (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
  •  John Connors
    (CEO & President, Jan Marini Skin Research)
  •  Mark Wilkins
    (Executive Vice President and U.S. General Manager, Prollenium Medical Technologies)
  •  Aaron Burton
    (CEO, Sciton)
  •  Jenna Mons Anderson
    (CEO, AccessElite)

You May Also Like

Journal of Drugs in Dermatology JDD Article about Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based DevicesAcneFeatured ArticlesLatest NewsSkincarePractical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices
March 12, 2026

Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices

A practical, consensus driven algorithm to help clinicians combine topical care and device therapies We wanted to share this February 2026 article that has been gaining a lot of attention.…
Journal of Drugs in Dermatology JDD Article about Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and DementiaFeatured ArticlesLatest NewsMedical DermAntiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia
March 11, 2026

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

A large real world TriNetX analysis reports an association between antiviral treatment for oral or mucocutaneous HSV and lower rates of Alzheimer disease and dementia If you’ve missed this must-read…
Journal of Drugs in Dermatology JDD Article about From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic ReviewFeatured ArticlesLatest NewsMedical DermFrom the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review
March 10, 2026

From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…

Leave a Reply